A Clinicopathological Study of CK5/6 and EGFR Expression in Triple-Negative Breast Cancers
Background and Objective: Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous subtype of breast cancer. Cytokeratin 5/6 (CK5/6) and epidermal growth factor receptor (EGFR) are basal markers that may be associated with tumour characteristics. This study aimed to evaluate CK5/6 and EGFR expression in...